pharmaphorum
pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Be sure to visit the podcast's website and support the creator: pharmaphorum.podbean.com
Author
pharmaphorum
Category
Podcast website
Latest episode
Nov 20, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Looking to the future of UK medical device exports 27.12.2023 24:37
In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders in...
Exploring the reasons behind increasing burdens on clinical research sites 26.12.2023 19:02
In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.
An investor’s perspective on bio and tech 21.12.2023 34:51
In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with LongeVC. His fund focused on therapeutics, diagnostics, and life sciences infrastructure plays.
Why digital therapeutics (DTx) are effective and safe, but not being prescribed 19.12.2023 20:13
In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.
AI drug discovery: Where we are and where we’re going 14.12.2023 34:26
Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime fellow to both the Royal Society and the Academy of Medical Sciences in the UK.
Retaining the human element in healthcare services whilst embracing the potential of robotics 12.12.2023 33:53
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology and business. Trained as a human-centric designer, Anderson helps align business strategy, purpose, and culture and tries to save the planet on the side. But, with his Academy of Robotics hat firmly in place, he’s also a player in the recent shift to...
Bringing women’s health up to speed for 21st Century human healthcare 07.12.2023 26:56
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and what Mithra is doing on an international scale to ameliorate that.
Creating a future where the healthcare ecosystem works for everyone 05.12.2023 38:31
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Ari Tulla, CEO and co-founder of Elo Health, about his ‘big vision’ to transform food – changing it from a leading cause of disease to the medicine it can be.
Key themes from Frontiers Health 2023, with the pharmaphorum team 30.11.2023 29:52
In today’s podcast, Nicole and Eloise sit down with host Jonah Comstock to talk about some of what they saw and heard at the show, including how digital health and digital therapeutics are shifting the paradigm of care sites, some lessons and discussions from the DtX Global Policy Summit, the World Economic Forum’s push for health equity and corporate accountability, and more.
Reducing the stigma attached to psychedelics 28.11.2023 31:41
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sarah Bateup, therapy lead at Clerkenwell Health, a British start-up working to revolutionise the clinical research landscape by providing a holistic one-stop hub for drug development, trial design, and treatment delivery for complex mental health and neurological conditions – including psychedelic medicines and...
How birth tissue donations are fuelling the cell therapy revolution 23.11.2023 39:11
On today’s podcast, host Jonah Comstock chats with Priya Baraniak, chief business officer and head of process development and manufacturing at OrganaBio and Lindsay Davis, chief scientific officer for NextCell Pharma, about how this tissue is currently collected and used and how this status quo may need to change.
Immunometabolism: Providing a new era of targeted medicine 21.11.2023 23:08
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.
Retaining the human element of AI within pharma and healthcare 16.11.2023 30:50
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.
Resilience, empathy, and gratitude. A personal battle with breast cancer. 14.11.2023 26:20
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer.
The ‘elegant science’ in achieving the promise of ADCs 07.11.2023 15:38
In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.
Understanding the importance of the whole person in clinical research 02.11.2023 20:45
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with KimberLee Heidmann, executive vice president of patient experience and customer success at Scout Clinical, part of Meeting Protocol Worldwide, a Dallas-based family of brands providing full-service meeting planning for the pharmaceutical and biotechnology industry, as well as clinical trial patient concierge travel...
Why medical weight loss is more complicated than GLP-1s 27.10.2023 24:33
This week the podcast welcomes Dr Rekha Kumar, medical affairs lead at digital medical weight loss clinic Found. Kumar discusses how her practice has had to carefully integrate these new drugs and navigate the complexities around prescribing them.
Creating behavioural change through incremental, small steps 24.10.2023 19:15
In this latest episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Sarah Watters, senior consultant at Wellth, a company devoted to improving the health of people with chronic conditions by embracing, not denying, humanity.
How AI can bolster each step of the clinical trial journey 19.10.2023 24:25
In today's podcast, brought to you by Syneos Health, host Jonah Comstock is joined by Baba Shetty, president of technology and data solutions at Syneos Health, to talk about about how he and his team are leveraging the power of data and artificial intelligence to address these many changing dynamics.
Focussing on finding value in health sciences marketing 17.10.2023 37:24
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.
How big pharma cares for its own 12.10.2023 27:01
On today’s podcast, host Jonah Comstock is joined by Jamie Eden, SVP of human resources at Boehringer Ingelheim, the world's largest private pharmaceutical company, for a conversation about what BI is doing to support the mental health of its workers.
Embracing the challenges and opportunities of digital health 10.10.2023 20:50
In this new instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dominic James, global head of digital health innovation and alliances at MSD on the topic of digital health.
How AI and omnichannel are transforming pharma marketing 05.10.2023 27:12
In today's podcast, sponsored by Viseven, host Jonah Comstock welcomes Nataliya Andreychuk, Viseven's CEO, to talk about how AI is changing the world of pharma marketing, what opportunities she's most excited about, and some of the areas where the right execution of this new technology might be challenging.
Digital therapeutics at a turning point: What we heard at DtX East 03.10.2023 35:46
Pharmaphorum Editor in Chief Jonah Comstock is joined on the podcast this week by friend-of-the-pod Eugene Borukhovich, who in addition to serving as COO of YourCoach Health also hosts the Digital Therapeutics Podcast, to discuss what they saw and heard at DtX East in Boston.
Understanding and addressing care disparities in rare cancers 28.09.2023 46:02
In today's podcast, sponsored by Oracle, host Jonah Comstock is joined by Otavio Clark, vice president of oncology at Cerner Enviza, an Oracle company, and Sheri McClerkin, an associate consultant in the Oncology & Specialty Therapeutics group at Cerner Enviza, to discuss the particular challenges of health inequity in the rare cancer space.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.